BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Scott Weiner will speak about Pappas Ventures' perspective on the Medtech market at the IN3 West: Investment in Innovation Conference in Las Vegas, NV.
News | 02. 22. 2011
